Institutions / Knott David M Jr

Knott David M Jr

CIK 1892770 · Institution · as of Dec 31, 2025
Portfolio value
$215.94M
Positions
87
As of
Dec 31, 2025

Top holdings

Dec 31, 2025View all 87 →
CompanyClassValueShares% of portfolio
Calumet, Inc. /DE$44.01M2,214,96920.4%
Apollo Global Management, Inc.$32.57M225,00015.1%
Alphabet Inc.$28.69M91,42013.3%
Syndax Pharmaceuticals Inc$8.72M415,0004.0%
Xeris Biopharma Holdings, Inc.$7.61M970,0003.5%
Travere Therapeutics, Inc.$7.11M186,0003.3%
BridgeBio Pharma, Inc.$6.50M85,0003.0%
Protagonist Therapeutics Inc$6.38M73,0003.0%
JPMORGAN CHASE & CO$6.28M19,4772.9%
Janus Henderson AAA CLO ETF$4.73M93,5282.2%
Viridian Therapeutics, Inc.$4.51M145,0002.1%
Catalyst Pharmaceuticals, Inc.$4.41M189,0002.0%
Cogent Biosciences, Inc.$3.62M102,0001.7%
Arcus Biosciences, Inc.$2.89M121,2411.3%
Alkermes plc.$2.66M95,0001.2%
DocGo Inc$2.34M2,670,8501.1%
Cybin Inc.$2.33M285,1821.1%
Cytokinetics Inc$2.16M34,0001.0%
AtriCure Inc$2.03M51,4000.9%
Alliancebernstein Holding L.P.ABMLP$1.85M48,0000.9%
Arcellx Inc$1.68M25,7000.8%
SPDR S&P Biotech ETF$1.59M13,0000.7%
Tectonic Therapeutic, Inc.TECXCommon Stock$1.54M74,0000.7%
Wave Life Science Ltd.$1.53M90,0000.7%
Johnson & Johnson$1.43M6,9220.7%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.